Close

LOGIN

Remember me
Not a member?
or
Connect using:
Why BS?

We encourage visitors to register on Business Standard. Registering on the site is absolutely Free and offers you the following benefits.

Free Daily E-newsletter

Breaking News Alerts in your Inbox

Post Comments and Share your Feedback

Your Personal Business Standard Page

Free Portfolio of Stocks, Equity and Commodities Derivatives

Access Premium Services

Receive Selective Offers from our Third Party Premium Advertisers

Get Invited to Business Standard Events

Close

FORGOT PASSWORD?

Not a member?

Aurobindo drug receives final approval

Related News

Aurobindo Pharma has received final approval for Venlafaxine Hydrochloride tablets 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg from the US Food and Drug Administration. These are generic equivalent of Wythe Pharmaceutical’s Effexor tablets.

The tablets are useful in treatment of major depressive disorder and falls under the therapeutic category of central nervous system. The product would be launched shortly. Aurobindo has a total 114 abbreviated new drug molecule approvals, a release said.

Read more on:   
|

Read More

Morgan Stanley upgrades ONGC, HPCL

Raises ratings to 'overweight' from 'equalweight'

Back to Top

Quick Links

Back to Top